0 likes | 11 Views
Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg, Germany.<br><br>Conference Registration Available @ https://shorturl.at/hzIN2<br>
E N D
Conference Takeaways • Preclinical and Translational Immuno-Oncology Developments • Biomarker Discovery Techniques • Precision Medicine Tailoring • Personalizing Cancer Treatment- Challenges and Opportunities • Rigorous Biomarker Validation • Bioinformatics and AI Analysis • Biomarker-Based Cancer Diagnostics Development
Conference Takeaways • Next Gen Antibodies and Targeted Therapies • Immune Checkpoint Inhibitors and Combination Therapies • Tumor Microenvironment and Cancer Biomarkers • CAR-T cell therapy, T Cell Therapy, Adoptive Cell Therapy • Cancer Vaccines and Cancer Microbiome • Collaboration for Advancement
Conference Registration Available @ https://shorturl.at/hzIN2